08:45 - 10:30
Thu-S7
Room: Conde de Cantanhede Theatre
Chair/s:
Elbrich Postma, Sanne Boesveldt
Olfactory bulb investigation in Parkinson's disease and olfactory dysfunctions
Oral presentation
Cécilia Tremblay 1, 2, Jie Mei 2, Geidy Serrano 1, Johannes Frasnelli 2, Thomas Beach 1
1 Civin Laboratory for Neuropathology, Banner Sun health Research Institute, 10515 West Santa Fe Drive, Sun City, AZ 85351, United Stated, 2 Department of Anatomy, Université du Québec à Trois-Rivières, 3351 Boul. des Forges, Trois-Rivières, Québec, G9A 5H7, Canada

Background: The olfactory bulb is one of the first regions of insult in Parkinson’s disease (PD), consistent with the early onset of olfactory dysfunction. Investigations of the olfactory bulb may, therefore, help early pre-motor diagnosis. We aimed to investigate olfactory bulb and its surrounding regions in PD-related olfactory dysfunction when specifically compared to other forms of non-parkinsonian olfactory dysfunction (NPOD) and healthy controls.
Methods: We carried out MRI-based olfactory bulb volume measurements from T2-weighted imaging in scans from 15 patients diagnosed with PD, 15 patients with either post-viral or sinonasal NPOD and 15 control participants. Further, we applied a deep learning model (convolutional neural network; CNN) to scans of the olfactory bulb and its surrounding area to classify PD-related scans from NPOD-related scans.
Results: Compared to controls, both PD and NPOD patients had smaller olfactory bulbs, when measured manually (both p < .001) whereas no difference was found between PD and NPOD patients. In contrast, when a CNN was used to differentiate between PD patients and NPOD patients, an accuracy of 88.3% was achieved. The cortical area above the olfactory bulb which stretches around and into the olfactory sulcus appears to be a region of interest in the differentiation between PD and NPOD patients.
Conclusion: Measures from and around the olfactory bulb in combination with the use of a deep learning model may help differentiate PD patients from patients with NPOD, which may be used to develop early diagnostic tools based on olfactory dysfunction.